The five laboratories awarded $35.5 million in late 2006 by the National Cancer Institutes to explore proteomics technologies for cancer research are concentrating on reproducibility issues, the ability to quantify proteins, and how different tissue and fluid matrices may affect discovery and validation, according to an NCI update earlier this month.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.